Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dementia
Clinical narrative: was diagnosed with dementia after receiving the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DEMENTIA (was diagnosed with dementia after receiving the Moderna COVID-19 vaccine) in a 78-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Concurrent medical conditions included Memory impairment (Patient had started to have Memory problems approximately 2 years ago).    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEMENTIA (was diagnosed with dementia after receiving the Moderna COVID-19 vaccine) (seriousness criterion medically significant). At the time of the report, DEMENTIA (was diagnosed with dementia after receiving the Moderna COVID-19 vaccine) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported.  Patient was diagnosed with dementia after receiving the Moderna COVID-19 vaccine, the exact date of diagnosis was not provided. Patient had experienced deteriorating dementia, there was no hospitalization required due to the dementia. Patient visited to health care provider as outpatient.  No treatment medications were reported.  Company Comment: This is a spontaneous case concerning a 78-year-old female patient with relevant medical condition of Memory impairment, who experienced the unexpected serious (medically significant) event of Dementia, described as deteriorating dementia, which was diagnosed after receiving a dose of mRNA-1273 vaccine. Latency cannot be properly assessed since vaccination date nor event onset date were provided. No further details about the clinical course, diagnostic procedures and treatments were provided. Patient have no previous hospitalization due to dementia and had medical consultation with her health care provider as an outpatient. It was reported that the patient had deteriorating dementia and was not resolved. The medical condition of Memory impairment could be a risk factor for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2022-617739.; Sender's Comments: This is a spontaneous case concerning a 78-year-old female patient with relevant medical condition of Memory impairment, who experienced the unexpected serious (medically significant) event of Dementia, described as deteriorating dementia, which was diagnosed after receiving a dose of mRNA-1273 vaccine. Latency cannot be properly assessed since vaccination date nor event onset date were provided. No further details about the clinical course, diagnostic procedures and treatments were provided. Patient have no previous hospitalization due to dementia and had medical consultation with her health care provider as an outpatient. It was reported that the patient had deteriorating dementia and was not resolved. The medical condition of Memory impairment could be a risk factor for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.